Join Your Colleagues for #CRSNYC!

Dear Current and Future Members of the Controlled Release Society:

I’m pleased to let you know that the 2018 CRS Annual Meeting and Exposition will be held in New York City, with this year’s meeting marking the 45th anniversary of CRS. Taking place July 22-24, the 2018 Annual Meeting features 10 Scientific Sessions, 6 Mini Symposia, 5 Focus Groups, 3 Pre-Meeting Workshops, about 30 Exhibitors, and 700 Abstracts submitted by those working in the field of Controlled Release. I am confident that this will be a very successful meeting and invite you to join us.

CRS is, in my opinion, one of the most respected and unique societies that covers new technologies and science in the multi-disciplinary delivery fields. CRS has succeeded in fostering significant progress in the areas of bioengineering, drug delivery, material science, pharmaceutics, consumer and diversified products, and veterinary science. With CRS’ members in more than 30 countries, as well as 15 local chapters throughout the world, our excellent annual meetings, and two prestigious CRS journals, the Journal of Controlled Release (impact factor in 2017 of 7.786, Editor-in-Chief Kinam Park) and the recently established journal Drug Delivery and Translational Research (impact factor in 2017 of 3.094, Editor-in-Chief Vinod Labha

setwar), we can look to the Society’s future with deserved optimism.

On behalf of CRS leadership, I am pleased to share some exciting updates that will help us continue to grow and move to the next level. First, due to our growth over the last few years, as well as our increasingly international character, CRS will be managed by a new firm. From now on, CRS will be managed by Association Headquarters (AH), Inc. (with Jean Maddalon, jmaddalon@controlledreleasesociety. org serving as Chief Operating Officer), which will provide us expertise, the highest level of customer service. Second, our updated website will enable us to share information with our community, including recent developments in our common areas, examples of how dynamic and challenging our science is, and how the CRS is trying to coordinate and promote joint efforts. Additionally, in the near future, we are considering many new initiatives, such as new benefits for members, new educational resources, and leadership opportunities for young scientists, that will bring more

 influence and visibility to the CRS, enhance its reputation, and drive increased revenue.

I would like to recognize and express my sincere gratitude to my colleagues who join me in leading CRS in 2017-2018. First of all, I’d like to express my appreciation to Immediate Past President Ruth Schmid (SINTEF Materials and Chemistry, Norway) for her tremendous efforts. She has led CRS with great dedication and passion during the past year and has made a lasting impact on our society through her leadership and through the implementation of changes to our annual meeting programming, increased industry focus, and updates to our strategic plan. I am very happy to work with the following CRS Board members: President-Elect Maria José Alonso (University of Santiago de Compostela, Spain), who successfully served on the Board in 2016–2017 as Secretary; current Secretary James Oxley (Southwest Research Institute, U.S.A.); Treasurer Jules Remenar (Dulce D Leche, U.S.A.); Treasurer-Elect Samir Mitragotri (Wyss Institute, Harvard University, U.S.A.); as well as five Directors-at-Large: Justin Hanes (John Hopkins University, U.S.A.), Richard W. Korsmeyer (retired from Pfizer, U.S.A.), Mark Prausnitz (Georgia Institute of Technology, U.S.A.), Nicole Papen-Botterhu

is (Maxima Medical Centre, the Netherlands), and Ilva Rupenthal (University of Auckland, New Zealand).

I am extremely grateful for the tremendous work of the members of Program Committee in preparing an outstanding program for 2018 CRS Annual Meeting : Chair – Hamid Ghandehari (University of Utah, U.S.A.); Co-Chairs - Twan Lammers (RWTH Aachen University, Germany), Yu-Kyoung Oh (Seoul National University, South Korea); Members - Thierry Vandamme (Université de Strasbourg, France), Tapashi Sengupta (Monsanto Company, U.S.A.), Kaushalkumar Dave (United States Food and Drug Administration, U.S.A.). I am also proud to report about the new CRS initiative – the formation of Focus Groups in the prominent areas of CRS. The focus groups will provide a leadership opportunity for young scientists. The initiator and frontrunner of this initiative is Steven R. Little (University of Pittsburgh, U.S.A.).

With all these achievements and activities on the horizon, CRS’ future is bright. Now is the ideal time to be a part of CRS, by maintaining your membership in the Controlled Release Society if you already are a member, becoming a CRS member if you have not done so before, and attending the 45th CRS Annual Meeting and Exposition in New York, July 22-24, 2018. This meeting offers not only an outstanding scientific program, but also a unique opportunity to meet our peers face-to-face and discuss how to maintain and enhance the significance of our society in years to come. Through our collective efforts, we can raise the Controlled Release Society and the existing science and technology we are involved in to a new level.


I look forward to seeing you in New York at the 2018 CRS Annual Meeting!

Tamara Minko, Ph.D.
President of the CRS